Hiroshi Kiyono of the University of Tokyo will work to advance a rice-based oral vaccine that can induce both mucosal and systemic immunity. If successful, the MucoRice system can be self-administered and will not require syringes or refrigeration.
Grant ID
OPP51787
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Initiatives
Principal Investigator
Award Manager
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
100000.00
Funding Currency
USD
Funding Amount (in USD)
100000.00
Project Type
Project Primary Sector
Funding Date Range
-
Funding Total (In US dollars)
100000.00
Co-Funded
False